M8 PHARMA

Serial Number 97898449
606

Registration Progress

Application Filed
Apr 20, 2023
Under Examination
May 21, 2024
Approved for Publication
Mar 6, 2024
Published for Opposition
Mar 26, 2024
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: M8 PHARMA
Previous Owner: Moksha8 Pharmaceuticals, Inc.
Classes: 035, 042

Trademark Image

M8 PHARMA

Basic Information

Serial Number
97898449
Filing Date
April 20, 2023
Published for Opposition
March 26, 2024
Abandonment Date
December 23, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 23, 2024
Classes
035 042

Rights Holder

Moksha8 Pharmaceuticals, Inc.

03
Address
#300
1055 Westlakes Drive
Berwyn, PA 19312

Ownership History

Moksha8 Pharmaceuticals, Inc.

Original Applicant
03
Berwyn, PA

Moksha8 Pharmaceuticals, Inc.

Owner at Publication
03
Berwyn, PA

Legal Representation

Attorney
Brendan J. Hughes

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

26 events
Date Code Type Description Documents
Dec 23, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 23, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 23, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Aug 23, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 23, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 23, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 21, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 26, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 26, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 6, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 6, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 16, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 16, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 16, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 16, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 16, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 16, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 16, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 16, 2024 ALIE A ASSIGNED TO LIE Loading...
Sep 26, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 26, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 26, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 26, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 26, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 16, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 24, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Consultation services related to sales management, sales promotion, and sales methods of biotechnology and pharmaceutical products and therapies
Class 042
Development of pharmaceutical products and therapies; consultation services related to development of biotechnology and pharmaceutical products and therapies

Additional Information

Pseudo Mark
M EIGHT PHARMA; MOKSHA EIGHT PHARMACEUTICALS

Classification

International Classes
035 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"